2 terminated. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
| Phase 3 | 2 | Terminated 2 |
Follow ADG20: new trials by email Literature Review of ADG20 trials Research Report on ADG20
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of ADG20 for the Treatment of Mild or Moderate COVID-19 ADG20, Normal saline - COVID-19 | Phase 2 / Phase 3 | Terminated | Invivyd, Inc. | 399 | 2021-07-26 | 2024-02-06 |
| Evaluation of ADG20 for the Prevention of COVID-19 ADG20, Placebo - COVID-19 | Phase 2 / Phase 3 | Terminated | Invivyd, Inc. | 2582 | 2021-04-27 | 2024-08-20 |
COVID-19 (2)
Invivyd, Inc. (2)
Argentina (2) · Germany (2) · Moldova (2) · Poland (2) · Romania (2) · Ukraine (2) · Brazil (1) · Bulgaria (1) · Czechia (1) · Georgia (1) · Greece (1) · Hungary (1) · South Africa (1) · United States (1)